期刊文献+

恶性淋巴瘤患者的染色体畸变 被引量:1

Chromosome Abnormalities of Malignant Lymphoma
下载PDF
导出
摘要 目的为了探讨恶性淋巴瘤(ML)染色体改变的规律及其与组织学分型的相关性。方法采用改良短期培养法制备24例ML患者的外周血染色体标本。结果24例ML进行了细胞遗传学研究,23例获得满意分裂相。所获得的ML患者的外周血染色体均显示不同程度的数目和(或)结构克隆异常,多涉及1,2,3,5,6,8,13,14,15,17,18,21号及X等染色体改变。不同的染色体畸变与ML的组织学分型有关。NHL的染色体众数以超二倍体、亚二倍体居多,HD以高异倍体、超二倍体、假二倍体居多。多种染色体结构改变涉及17p、1p、1q、2p、2q,提示这些部位的丢失或断裂重排与ML的发生有关。结论细胞遗传学与组织病理学结合起来,有助于ML的分类,并对探讨ML的发生机制、临床诊治和预后判断具有一定的意义。 Objective To explore the relativity of chromosome abnormalities in malignant lymphoma (ML) and its relevance to histopathology. Methods The cytogenetic study on 24 patients with ML by the methods of short term culture to prepare the chromosome from peripheral blood. Results Mitotic cells that could be used for analysis were found in 23 cases, h showed that the numerical and/or structural abnormalities of clone chromosome were found in all patients with ML and were often involved in chromosomes 1,2,3,5,6, 8,13,14,15,17,18,21 and X. The chromosome aberrations were associated with the histopathological type of ML in some extent. The hyperdiploid and hypodiploid of chromosome were mostly seen in patients with Non-Hodgin's lymphoma(NHL), whereas the polyploid and hyperdiploid and pseudodiploid were mostly seen in Hodgkin's disease(HD). Many structure aberrations of chromosome involved in 17p, 1 p, 1 q,2p ,2q, which suggested that the structure deletion and breakpoint region should be associated with ML. Conclusions The combination of the cytogenetic and pathologic study could be benefit to classification, pathogenesis, diagnosis, treatment and prognosis of ML.
出处 《肿瘤基础与临床》 2006年第2期103-105,共3页 journal of basic and clinical oncology
关键词 恶性淋巴瘤 染色体 外周血 malignant lymphoma chromosome peripheral blood
  • 相关文献

参考文献8

  • 1周俊,翁立红,张颜明,顾文祥.应用原位杂交和细胞遗传学方法检测淋巴瘤患者的染色体畸变[J].癌症,2000,19(6):538-540. 被引量:2
  • 2Fonatsch C. Cytogenetics of malignant lymphomas [J].Blut, 1988,57 (3) :101 - 109.
  • 3Faharius A, Hehlmanna R, Duesbergb PH. Instability of chromosome structure in cancer cells increases exponentially with degrees of aneuploidy[J].Cancer Genet and Cytogenet, 2003,143(1):59 - 72.
  • 4Starostik P, Patzner J, Greiner A, et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways[J]. Blood, 2002,99(1):3 - 9.
  • 5Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia[J]. Proc Natl Acad Sci USA, 1991,88(12) :5413-5417.
  • 6Ichikawa A, Hotta T, Saito H. Mutations of the p53 gene in B-cell lymphoma[J]. Leuk Lymphoma, 1993, 11 ( 1 - 2) :21 - 25.
  • 7Prie-Danoewinata H, Chott A, Onderka E, et al. Karyotype and prognosis in non-Hodgkin's lymphoma[J]. Leukemia, 1994,84(11):1929 - 1939.
  • 8Tilly H, Basterd C, Delastre T, et al. Cytogenetic studies in untreated Hodgkin' s disease[J]. Blood, 1991, 77(6) : 1298 - 1304.

二级参考文献3

共引文献1

同被引文献27

  • 1周容,卢洁,董增义,谷仁凯,林荣军.小儿恶性淋巴瘤的细胞遗传学研究[J].中华儿科杂志,1996,34(3):161-163. 被引量:1
  • 2GangSong,GaoliangOuyang,ShidengBao.The activation of Akt/PKB signaling pathway and cell survival[J]. Journal of Cellular and Molecular Medicine . 2007 (1)
  • 3M. Osaki,M. Oshimura,H. Ito.PI3K-Akt pathway: Its functions and alterations in human cancer[J]. APOPTOSIS . 2004 (6)
  • 4Sen R,Baltimore D.Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell . 1986
  • 5Marina Y. Konopleva,Craig T. Jord.Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting. Japanese Journal of Clinical Oncology . 2011
  • 6Tokunaga Eriko,Oki Eiji,Egashira Akinori,Sadanaga Noriaki,Morita Masaru,Kakeji Yoshihiro,Maehara Yoshihiko.Deregulation of the Akt pathway in human cancer. Current Cancer Drug Targets . 2008
  • 7Coffer P J,Jin J,Woodgett J R.Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochemical Journal . 1998
  • 8LQiu,LZhang,LZhu,DYang,ZLi,KQin,XMi.??PI3K/Akt mediates expression of TNF‐α mRNA and activation of NF‐κB in calyculin A‐treated primary osteoblasts(J)Oral Diseases . 2008 (8)
  • 9Mehra Sukvarsha,Messner Hans,Minden Mark,Chaganti R S K.Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines. Genes Chromosomes and Cancer . 2002
  • 10Mattias Berglund,Gunilla Enblad,Ulf Thunberg,Rose-Marie Amini,Christer Sundstr?m,G?ran Roos,Martin Erlanson,Richard Rosenquist,Catharina Larsson,Svetlana Lagercrantz.Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma. Modern Pathology . 2006

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部